This topic contains a solution. Click here to go to the answer

Author Question: Even when preferences are _____, the _____ will produce a single winner. a. not single peaked; ... (Read 63 times)

luminitza

  • Hero Member
  • *****
  • Posts: 555
Even when preferences are _____, the _____ will produce a single winner.
 
  a. not single peaked; equilibrium
  b. single peaked; log-rolling
  c. cyclical; majority rule system
   d. cyclical; primary system

Question 2

A small business owner earns 60,000 in revenue annually. The explicit annual costs equal 40,000. The owner could work for someone else and earn 25,000 annually. The owner's accounting profit is ________ and owner's economic profit is ________.
 
  A) 20,000, 5,000
  B) 20,000, -5,000
  C) 25,000, -5,000
  D) 45,000, -5,000



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Eazy416

  • Sr. Member
  • ****
  • Posts: 360
Answer to Question 1

d

Answer to Question 2

B




luminitza

  • Member
  • Posts: 555
Reply 2 on: Jul 1, 2018
Thanks for the timely response, appreciate it


tkempin

  • Member
  • Posts: 332
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

The tallest man ever known was Robert Wadlow, an American, who reached the height of 8 feet 11 inches. He died at age 26 years from an infection caused by the immense weight of his body (491 pounds) and the stress on his leg bones and muscles.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library